News in Science Updates

UW researchers, there's still time! You are encouraged to submit your research and review papers to be considered for an upcoming special issue of Alzheimer's & Dementia: The Journal of the Alzheimer's Association®.

Read More

Categories: Science Updates

For these studies, researchers used data from participants in the UW ADRC Clinical Core, with gratitude.

Read More

Categories: Science Updates, Dimensions 2024

Swati Rane Levendovszky, PhD, an associate professor of radiology at the University of Washington, explores blood vessel pathology and its relation to Alzheimer’s disease in the living brain using brain imaging. Her work on UW, national, and worldwide research projects has propelled her to new levels of leadership in the UW Alzheimer's Disease Research Center.

Read More

Categories: Science Updates, Team Spotlights, Dimensions 2024

Enjoy the latest issue of Dimensions Magazine! Find inside the latest findings in Alzheimer's and brain health research, a faculty spotlight, and a new conversation game meant to preserve memories and legacy, and so much more.

Read More

Categories: Science Updates, Care & Treatment , Team Spotlights, Community Stories, Caregiving, Resources, Brain Health, Dementia-Friendly Community

The Commission is authored by 27 dementia experts, including the UW ADRC’s Eric B. Larson, MD, MPH, who is affiliate professor of medicine in the UW School of Medicine, who has now worked on all three Lancet reports that make recommendations for policy makers and individuals to help reduce dementia risk worldwide. Larson gives us context for the new recommendations and shares how UW research has influenced this report.

Read More

Categories: Science Updates, Care & Treatment , Brain Health Awareness

"Donanemab's compelling clinical trial outcome not only confirms that this treatment strategy is effective in treating Alzheimer's disease, but also provides clinicians additional opportunities to tailor the amyloid monoclonal antibody to the individual patient," said MBWC Clinical Trials Director, Michael Rosenbloom, MD

Read More

Categories: Science Updates, New FDA Drug Approvals

Research looking at the link between Alzheimer’s disease and eye problems is based on ongoing ACT study started in 1994.

Read More

Categories: Science Updates

Congratulations to the investigators who were awarded 2024-2025 Developmental Project Grants of the UW MBWC’s Alzheimer’s Disease Research Center. These projects will use ADRC resources and participant data in studies on the cutting edge of research into Alzheimer’s and related dementias.

Read More

Categories: Science Updates

The drug has been shown to reduce cognitive decline in patients with early Alzheimer's.

Read More

Categories: Science Updates, New FDA Drug Approvals

For these studies, researchers used data from participants in the UW ADRC Clinical Core, with gratitude.

Read More

Categories: Science Updates